Home Cart 0 Sign in  
X

[ CAS No. 51656-91-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 51656-91-8
Chemical Structure| 51656-91-8
Chemical Structure| 51656-91-8
Structure of 51656-91-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 51656-91-8 ]

Related Doc. of [ 51656-91-8 ]

Alternatived Products of [ 51656-91-8 ]
Product Citations

Product Details of [ 51656-91-8 ]

CAS No. :51656-91-8 MDL No. :MFCD07779434
Formula : C12H18O4 Boiling Point : -
Linear Structure Formula :- InChI Key :UIWISFUVNHCOBJ-UHFFFAOYSA-N
M.W : 226.27 Pubchem ID :373318
Synonyms :

Calculated chemistry of [ 51656-91-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.75
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 58.59
TPSA : 44.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.95 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.83
Log Po/w (XLOGP3) : 1.03
Log Po/w (WLOGP) : 1.79
Log Po/w (MLOGP) : 1.33
Log Po/w (SILICOS-IT) : 2.43
Consensus Log Po/w : 1.88

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.69
Solubility : 4.58 mg/ml ; 0.0202 mol/l
Class : Very soluble
Log S (Ali) : -1.56
Solubility : 6.23 mg/ml ; 0.0275 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.09
Solubility : 1.85 mg/ml ; 0.00818 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.37

Safety of [ 51656-91-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 51656-91-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 51656-91-8 ]
  • Downstream synthetic route of [ 51656-91-8 ]

[ 51656-91-8 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 4746-97-8 ]
  • [ 51656-91-8 ]
YieldReaction ConditionsOperation in experiment
91%
Stage #1: With sodium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; for 0.5 h;
Stage #2: at 0 - 20℃; for 18 h;
A solution of triethyl phosphonate (44.8 g, 200 mmol) in THF (30 ml) at 0° C. was treated with a 1M solution (200 ml) of sodium bis(trimethylsilylamide) in THF. The resulting mixture was stirred at room temperature for 0.5 hour, and then cooled to 0° C. A solution of 1,4-cyclohexanedione mono ethylene ketal (15.6 g, 200 mmol) in THF (50 ml) was added dropwise, and the resulting solution was stirred at room temperature for 18 hours. The reaction mixture was then cooled to 0° C., treated with cold aqueous citric acid, and the mixture was extracted with EtOAc. The extract was washed with satd. aqueous NaHCO3, brine, dried over Na2SO4, filtered, and the filtrate was concentrated. The residue was chromatographed on silica gel, eluting with a gradient of CH2Cl2/EtOAc to afford 223b (21 g, 91percent).
Reference: [1] Patent: US2006/264489, 2006, A1, . Location in patent: Page/Page column 77-78
[2] Patent: US5877199, 1999, A,
[3] Patent: WO2006/115168, 2006, A1, . Location in patent: Page/Page column 106-107
[4] Patent: WO2007/73934, 2007, A1, . Location in patent: Page/Page column 92-93
[5] Patent: WO2004/99191, 2004, A2, . Location in patent: Page 17
[6] Patent: WO2007/128568, 2007, A1, . Location in patent: Page/Page column 92-94
  • 2
  • [ 4746-97-8 ]
  • [ 867-13-0 ]
  • [ 51656-91-8 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 1 h;
Stage #2: at -20 - 20℃; for 3 h;
To a solution of NaH (60percent mineral oil suspension, 33.3 g, 832.38 mmol) in anhydrous THF (1 L) was added dropwise a solution of l,4-dioxaspiro[4.5]decan-8-one (100 g, 640.29 mmol) in anhydrous THF (500 mL) at 0 °C for 1 hour. The reaction was stirred at 0 °C for 1 hour, then triethyl phosphonoacetate (172.26 g, 768.35 mmol) was added dropwise at -20 °C for 1 hour. The reaction was allowed to warm to room temperature and stirred for 2 hours. The mixture was diluted with H2O (1 L) and extracted with EtOAc (1 L x 3). The combined organic phases were washed with brine (1 L), dried over anhydrous Na2SO i, filtered and concentrated in vacuo. The residue was purified by silica gel column chromatography (PE/EtAOc (v/v) = 10/1) to give the title compound as light yellow oil (145 g, 100 percent). 1H M (600 MHz, CDCI3): δ (ppm) 5.62 (s, 1H), 4.10 (qd, / = 7.1, 2.9 Hz, 2H), 3.94 (d, J = 13.8 Hz, 4H), 2.99-2.89 (m, 2H), 2.37-2.27 (m, 2H), 1.77-1.66 (m, 4H), 1.23 (td, J = 7.1, 2.7 Hz, 3H).
100%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 2 h;
Stage #2: at -20 - 20℃; for 3 h;
Step 1) ethyl 2-(l,4-dioxaspiro[4.51decan-8-ylidene)acetate [0342] To a suspension of NaH (60percent mineral oil suspension, 33.3 g, 832.38 mmol) in anhydrous THF (1 L) was added a solution of l,4-dioxaspiro[4.5]decan-8-one (100 g, 640.29 mmol) in anhydrous THF (500 mL) dropwise at 0 °C for 1 h and continued to stir for 1 h. Then triethyl phosphonoacetate (203.23 g, 832.38 mmol) was added to the above suspension dropwise at -20 °C in 1 h. The resulting mixture was allowed to warm to rt, stirred for 2 h, quenched with H20 (1 L) and extracted with EtOAC (1 L x 3). The combined organic phases were washed with brine (1 L), dried over anhydrous Na2S04, then filtered and concentrated in vacuo. The residue was purified by silica gel column chromatography (EtOAc/PE (v/v) = 1/10) to give the title compound as pale yellow oil (157 g, 100 percent). FontWeight="Bold" FontSize="10" H NMR (600 MHz, CDCI3): δ (ppm) 5.64 (s, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.95 (s, 4H), 2.97 (m, 2H), 2.36 (m, 2H), 1.74 (m, 4H), 1.25 (t, J= 7.2 Hz, 4H).
100%
Stage #1: With potassium <i>tert</i>-butylate In N,N-dimethyl-formamide at 20℃; for 0.166667 h;
Stage #2: at 20℃; for 1 h;
Potassium tert-butylate (10.7 g, 95.6 mmol) was added to a solution of phosphonoacetic acid triethyl ester (21.4 g, 19 ml, 95.6 mmol) in anhydrous N,N-dimethylformamide (90 ml) underargon and the mixture was stirred for 10 mm at room temperature. A solution of 1,4- dioxaspiro[4.5]decan-8-one (10.0 g, 64 mmol) in anhydrous N,N-dimethylformamide (160 ml) was then added to the mixture and the mixture was stirred for 1 h at room temperature and then poured into ice-water (240 g). The aqueous suspension was extracted with diethyl ether (4 x 100 ml). The combined organic extracts were dried with sodium sulfate andconcentrated i. vac.Yield: 14.4 g (100 percent), yellowish oil.1H-NMR (CDCI3): 1.27 (3 H, t, J = 7.1 Hz): 1.73—1.80 (4 H, m); 2.35—2.40 (2 H, m); 2.92—3.02(2 H, m): 3.97 (4 H, s): 4.15 (2 H, q, J = 7.1 Hz): 5.66(1 H, s).
100%
Stage #1: With sodium hydride In tetrahydrofuran; water; mineral oil at -20 - 0℃;
Stage #2: at 20℃; for 3 h;
The NaH (60percent mineral oil suspension, 33.3g, 832 . 38mmol) THF suspended water-free (1L) in, in 0 °C lower, added to the 1,4-dioxaspiro [4.5] decane-8-one (100g, 640.29mmol) anhydrous THF (500 ml) solution, 1-hour internal dropping end. Furthermore, at -20 °C lower, the phosphoryl acetic acid triethyl ester (203.23g, 832 . 38mmol) is dripped into the in the above-mentioned suspension system, 1-hour internal dropping end. The resulting system is moved to the room temperature, is continuously stirred for 2 hours, then water (1L) quenching the reaction, and using ethyl acetate (1Lx3) extraction. Combined with the phase, saturated salt water for (1L) washing, anhydrous Na2SO4drying, concentrated filtrate under reduced pressure, the resulting residue by a silica gel column chromatography (PE/EtOAc = 10/1 (v/v)) purification, to obtain the title compound as of bombycinous (157g, 100percent).
100%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 2 h;
Stage #2: at -20 - 20℃; for 3 h;
Step 1) ethyl 2-(l ,4-dioxaspiror4.51decan-8-ylidene)acetate [0350] To a suspension of NaH (60percent mineral oil suspension, 33.3 g, 832.38 mmol) in anhydrous THF (1 L) was added a solution of l ,4-dioxaspiro[4.5]decan-8-one (100 g, 640.29 mmol) in anhydrous THF (500 mL) dropwise at 0 °C for 1 h and the reaction mixture was stirred for another 1 h. Then, triethyl phosphonoacetate was added dropwise to the above suspension at -20 °C in 1 h. The resulting mixture was allowed to warm to rt, and stirred for another 2 h, then quenched with 0 (1 L) and extracted with EtOAc (1 L x 3). The combined organic phases were washed with brine (1 L), then dried over anhydrous Na2S04, filtered and concentrated in vacuo. The residue was purified by silica gel column chromatography (EtOAc/PE (v/v) = 1/10) to give the title compound as pale yellow oil (157 g, 100 percent). NMPv (600 MHz, CDCb): δ (ppm) 5.64 (s, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.95 (s, 4H), 2.97 (m, 2H), 2.36 (m, 2H), 1.74 (m, 4H), 1.25 (t, J= 7.2 Hz, 4H).
100%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.5 h; Inert atmosphere
Stage #2: at 20℃; for 2 h;
To a suspension of NaH (60percent suspension in oil) (1.42 g, 35.45 mmol) in THF (190mL) at 0 °C, under N2, ethyl 2-(diethoxyphosphoryl)acetate (7 mL, 35.45 mmol) was addeddrop-wise. The mixture was stirred for 30’, then 1,4-dioxaspiro[4.5]decan-8-one (5g, 32 mmol)in THF (20 mL) was added drop-wise. The resulting mixture was stirred at RT for 2 hrs and thenconcentrated under vacuum. The residue was taken up with Et20, washed with water and Brine, dried over Na2SO4 and concentrated to obtain 7.58 g of title compound (p121, y= quant) as colourless oil. MS (m/z): 227.2 [IVIH]t
100% With sodium hydride In tetrahydrofuran; mineral oil at -20 - 20℃; for 2 h; NaH (60percent suspended in mineral oil, 33.3 g, 832.38 mmol) was suspended in dry THF (1 L), and then the suspension was placed at 0 ° C, 1,4-dioxaspiro[4.5]decan-8-one (100 g, 640.29 mmol) in dry THF (500 mL) dropwise over 1 hour to give a suspension. Then, triethyl phosphonoacetate (203.23 g, 832.38 mmol) was added dropwise to the above suspension at -20 ° C, and the mixture was dropwise added in 1 hour to obtain a reaction system. The resulting reaction was moved to room temperature and stirring continued for 2 hours, then the reaction was quenched with water (1 L) and extracted with ethyl acetate (1 L x 3). The combined organic phases were washed with brine (1 L), then dried over anhydrous Na2SO4, filtered and the filtrate was concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (PE / EtOAc (v / v) = 10/1) to give the title compound as a pale yellow oil (157 g, 100percent).
100% With sodium hydride In tetrahydrofuran; kerosene at -20 - 20℃; for 4 h; At 0 ° C, NaH (60percent [w / w], 33.3 g, 832.38 mmol) suspended in kerosene was added to dry tetrahydrofuran (500 mL) and 1,4-dioxaspiro[4.5]decan-8-one (100 g, 640.29 mmol) was added dropwise over 1 hour. Then triethyl phosphonoacetate (172.26 g, 768.35 mmol) was added dropwise at -20 ° C for 1 hour. The reaction was warmed to room temperature and stirred for 2 hours before it was diluted with water (1 L), extracted with ethyl acetate (1 L × 3), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate (v / v) = 10/1) to give the title compound as a pale yellow oil (145 g, 100percent).
96%
Stage #1: With sodium hydride In tetrahydrofuran at 0 - 20℃; for 0.5 h;
Stage #2: at 0 - 20℃; for 0.5 h;
Triethyl phosphonoacetate (21.79 ml, 109 mmol) was added to a suspension of sodium hydride (3.84 g, 96 mmol) in THF (64.0 ml) and 0 °C. Reaction was stirred at room temperature for 30 minutes. After 30 minutes, the reaction was recooled to 0 °C and a solution of 1,4-dioxaspiro[4.5]decan-8-one (10 g, 64.0 mmol) in 5 mL THF wasadded. The reaction was then stirred at room temperature for 30 minutes prior to quenching with water. The mixture was extracted with DCM three times. Combined organic extracts were dried with sodium sulfate, filtered, and concentrated in vacuo. Crude residue was purified via silica gel chromatography to give Intermediate 71A (13.88 g, 61.3 mmol, 96percent yield). TLC: product stains as purple spot in anisaldehyde (Rf= 0.75in 1:1 Hex/EtOAc). ‘H NMR (400 MHz, chloroform-d) ö: 5.65 (s, 1H), 4.13 (q, J=7.2 Hz,2H), 3.92-3.99 (m, 4H), 2.94-3.02 (m, 2H), 2.3 1-2.40 (m, 2H), 1.71-1.79 (m, 4H), 1.26 (t, J=7.2 Hz, 3H).
96%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; for 0.5 h;
Stage #2: at 0 - 20℃; for 0.5 h;
Triethyl phosphonoacetate (21.79 ml, 109 mmol) was added to a suspension of sodium hydride (3.84 g, 96 mmol) in THF (64.0 ml) and 0 °C. Reaction was stirred at room temperature for 30 minutes. After 30 minutes, the reaction was recooled to 0 °C and a solution of l,4-dioxaspiro[4.5]decan-8-one (10 g, 64.0 mmol) in 5 mL THF was added. The reaction was then stirred at room temperature for 30 minutes prior to quenching with water. The mixture was extracted with DCM three times. Combined organic extracts were dried with sodium sulfate, filtered, and concentrated in vacuo. Crude residue was purified via silica gel chromatography to give Intermediate 83A (13.88 g, 61.3 mmol, 96percent> yield). TLC: product stains as purple spot in anisaldehyde (Rf = 0.75 in 1 : 1 Hex/EtOAc). 1H NMR (400 MHz, chloroform-d) δ: 5.65 (s, 1H), 4.13 (q, J=7.2 Hz, 2H), 3.92-3.99 (m, 4H), 2.94-3.02 (m, 2H), 2.31-2.40 (m, 2H), 1.71-1.79 (m, 4H), 1.26 (t, J=7.2 Hz, 3H)
96%
Stage #1: With sodium hydride In tetrahydrofuran at 0 - 20℃; for 1 h;
Stage #2: at 0 - 20℃; for 0.5 h;
Triethyl phosphonoacetate (21.79 ml, 109 mmol) was added to a suspension ofsodium hydride (3.84 g, 96 mmol) in THF (64.0 ml) and 0 °C. Reaction was stirred atroom temperature for 30 minutes. After 30 minutes, the reaction was recooled to 0 °C and a solution of 1,4-dioxaspiro[4.5]decan-8-one (10 g, 64.0 mmol) in 5 mL THF was added. The reaction was then stirred at room temperature for 30 minutes prior to quenching with water. The mixture was extracted with DCM three times. Combinedorganic extracts were dried with sodium sulfate, filtered, and concentrated in vacuo. Crude residue was purified via silica gel chromatography to give Intermediate 305A (13.88 g, 61.3 mmol, 96percent yield). TLC: product stains as purple spot in anisaldehyde (Rf = 0.75 in 1:1 Hex/EtOAc). ‘H NMR (400 MHz, chloroform-d) ö: 5.65 (s, 1H), 4.13 (q, J7.2 Hz, 2H), 3.92-3.99 (m, 4H), 2.94-3.02 (m, 2H), 2.3 1-2.40 (m, 2H), 1.7 1-1.79 (m,4H), 1.26 (t, J7.2 Hz, 3H).
96%
Stage #1: With sodium hydride In tetrahydrofuran at 0 - 20℃; for 0.5 h;
Stage #2: at 0 - 20℃; for 0.5 h;
[00187] Tri ethyl phosphonoacetate (21.79 ml, 109 mmol) was added to a suspension of sodium hydride (3.84 g, 96 mmol) in THF (64.0 ml) and 0 °C. Reaction was stirred at room temperature for 30 minutes. After 30 minutes, the reaction was recooled to 0 °C and a soution of l,4-dioxaspiro[4.5]decan-8-one (10 g, 64.0 mmol) in 5 mL THF was added. The reaction was then stirred at room temperature for 30 minutes prior to quenching with water. The mixture was extracted with DCM three times. Combined organic extracts were dried with sodium sulfate, filtered, and concentrated in vacuo. Crude residue was purified via silica gel chromatography to give intermeduate 3A (13.88 g, 61.3 mmol, 96 percent yield). TLC: product stains as purple spot in anisaldehyde (Rf = 0.75 in 1 : 1 Hex/EtOAc). NMR (400 MHz, CHLOROFORM-d) δ: 5.65 (s, 1H), 4.13 (q, J=7.2 Hz, 2H), 3.92-3.99 (m, 4H), 2.94-3.02 (m, 2H), 2.31 -2.40 (m, 2H), 1.71 -1.79 (m, 4H), 1.26 (t, J=7.2 Hz, 3H)
96%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; for 0.5 h;
Stage #2: at 0 - 20℃; for 0.5 h;
Triethyl phosphonoacetate (21.79 ml. 109 mmoi) was added to a suspension of sodium hydride (3.84 g, 96 mrnol) in TI-iF (64.0 ml) and 0 °C. Reaction was stirred at room temperature for 30 minutes. After 30 minutes, the reaction was recooled to 0 C and a soution of 1,4-dioxaspiro[4.5Idecan-8-one (10 g, 64.0 mmol) in 5 mL THF was added. The reaction was then stirred at room temperature for 30 minutes prior to quenching with water, The mixture was extracted with DCM three times. Combined organic extracts were dried with sodium sulfate, filtered, and concentrated in vacuo. Crude residue was purified via silica gel chromatography to give intermediate 13A (13.88 g, 61.3 mmoi, 96 percent yield). TLC: product stains as purple spot in anisaldeliyde (RI 0 7 in 11 He [tO’\.c) ‘HMR(400 MHz (HLOROH)RNI-d) 5 565 (1H), 4.13 (q, J=7.2 Hz, 2Ff), 3.92-3.99 (m, 4H), 2.94-3.02 (in, 2H), 2.31-2.40 (m, 2H). 1.71-1.79 (in, 4H), 1.26 (t, J=7.2 Hz, 3H)
94%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 1 h;
Stage #2: at -20 - 20℃;
Step-1:
Ethyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate
A solution of compound 1 (10.05 g, 64.04 mmol, 1.0 eq.) in THF (30 ml) was added dropwise to a suspension NaH (1.84 g, 76.85 mmol, 1.2 eq.) in THF (90 ml) at 0° C. and the mixture was stirred at same temperature for 1 h.
Triethyl phosphonoacetate (16.5 ml, 83.25 mmol, 1.3 eq.) was added to the reaction mixture at -20° C. and the reaction mixture was allowed to warm to RT and stir for 2 h.
The reaction mixture was diluted with ethyl acetate (100 ml), washed with water (2*100 ml) and the organic layer dried over sodium sulfate.
The solvent was evaporated under reduced pressure to obtain the crude product which was purified by column chromatography (silica gel; 5percent ethyl acetate/hexanes) to yield compound 2. Yield: 94percent (17.28 g, 60.2 mmol).
93%
Stage #1: With lithium hydride In tetrahydrofuran at 20℃; for 1 h;
Stage #2: at 65℃; for 16 h;
To a solution of THF (18 mL) under argon was added 0.38 g (47.8 mmol, 5 equiv) of LiH, followed by slow addition of 8.78 G (47.8 mmol, 5 equiv) of triethyl phosphonoacetate. The solution was stirred at rt for 1 h and 1.49 g (9.6 mmol, 1 equiv) of 1, 4-cyclohexanedione mono-ethylene ketal was added and the solution was heated at 65 °C for 16 h. Upon cooling the solution was treated with MeOH (10 mL) and water (5 mL) and concentrated in vacuo. The resulting yellow oil was purified by silica gel chromatography eluting with 4: 1 Hex/EtOAc to yield 1.89 g (93percent) of a clear oil.'H-NMR (CDCI3-D) 8 5.67 (s, 1H), 4.16 (t, 2H), 3.99 (m, 4H), 3.02 (m, 2H), 2.39 (m, 2H), 1.78 (m, 4H), 1.29 (t, 3H); LCMS RT = 2.56 min; [M+H] + = 226.9.
93%
Stage #1: With lithium hydride In tetrahydrofuran at 20℃; for 1 h;
Stage #2: at 65℃; for 16 h;
Example 1; Preparation of ethyl [4-({3-chloro-4-[(3-fluorobenzyl)oxy] phenyl )amino)[1]benzothieno[2,3-d]pyrimidin-7-yl]acetate; Step 1. Preparation of ethyl 1,4-dioxaspiro[4.5]dec-8-ylideneacetate; To a solution of THF (18 mL) under argon was added 0.38 g (47.8 mmol, 5 equiv) of LiH, followed by slow addition of 8.78 g (47.8 mmol, 5 equiv) of triethyl phosphonoacetate. The solution was stirred at rt for 1 h and 1.49 g (9.6 mmol, 1 equiv) of l,4-dioxa-spiro[4.5]decan-8-one was added and the solution was heated at 65°C for 16 h. Upon cooling the solution was treated with MeOH (10 mL) and water (5 mL) and concentrated in vacuo. The resulting yellow oil was purified by silica gel chromatography eluting with 4: 1 Hex/EtOAc to yield 1.89 g (93percent) of a clear oil. 1H- NMR (CDCl3-d) δ 5.67 (s, 1H), 4.16 (t, 2H), 3.99 (m, 4H), 3.02 (m, 2H), 2.39 (m, 2H), 1.78 (m, 4H), 1.29 (t, 3H); LCMS RT = 2.56 min, [M+H]+ = 226.9.
93%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.5 h; Inert atmosphere
Stage #2: at 0 - 25℃; for 3 h; Inert atmosphere
Triethyl phosphonoacetate (12.2g, 54.4mmol) was dissolved in tetrahydrofuran (100mL), at 0 °C was added sodium hydride (1.92g, 48.0mmol), the reaction mixture was stirred under nitrogen atmosphere for 30 minutes.Then at 0 °C dissolved in tetrahydrofuran (15mL) 1,4-cyclohexanedione monoethylene ketal (5.00g, 32.0mmol) was added dropwise to the reaction mixture, the reaction solution was stirred at 25 °C for 3 hours. Water was added (25mL) to quench the reaction and extracted with dichloromethane (20mLx3). The combined organic phase was washed with saturated brine (20 mL), dried over anhydrousOver sodium sulfate, and concentrated under reduced pressure, the residue was residue was purified by silica gel column chromatography (5: 1 petroleum ether / acetic acidEthyl ester, Rf = 0.3), give ethyl 2-(1,4-dioxa-spiro[4.5]decane-8-ylidene)acetate (6.30g, Colorless oil). Yield: 93percent.
90%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.5 h;
Stage #2: at 0℃; for 16 h;
A solution of triethyl phosphonoacetate (11 mmol) in THF (50 ml) was added slowly to a suspension, cooled to 0° C., of NaH (10 mmol) in THF (50 ml), and the reaction mixture was stirred for 30 min. 1,4-Dioxa-spiro[4.5]decan-8-one (10 mmol) in THF (50 ml) was then added dropwise at 0° C., and stirring was carried out for 16 h. After addition of ice and aqueous saturated NaCl solution, the aqueous phase was washed with ethyl acetate and the organic phase with water and aqueous saturated NaCl solution. The combined organic phases were dried over Na2SO4 and, after filtration, the solvent was removed in vacuo. The product was purified by column chromatography (20percent ethyl acetate/hexane). Yield: 90percent.
83% With sodium hydride In tetrahydrofuran at 0℃; Into a 250-mL round-bottom flask, was placed ethyl 2-(diethoxyphosphoryl)acetate (14.4 g, 64.23 mmol, 1 equiv), tetrahydrofuran (150 mL), sodium hydride (5.12 g, 213.33 mmol, 3.33 equiv), l,4-dioxaspiro[4.5]decan-8-one (10 g, 64.03 mmol, 1 equiv). The resulting solution was stirred overnight at 0 °C. The reaction was then quenched by the addition of 50 mL of water. The resulting solution was extracted with 3x50 mL of ethyl acetate and the organic layers combined. The resulting mixture was washed with 3x50 mL of H2O. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1 :5). This resulted in 12 g (83percent) of as a yellow liquid. Analytical Data: 1H NMR (300 MHz, Chloroform-d) δ 5.67 (p, J= 1.1 Hz, 1H), 4.15 (q, J= 7.1 Hz, 2H), 3.98 (s, 4H), 3.00 (ddd, J= 7.8, 5.1, 1.2 Hz, 2H), 2.44 - 2.32 (m, 2H), 1.84 - 1.70 (m, 4H), 1.28 (t, J= 7.1 Hz, 3H).
69%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 1 h;
Stage #2: at 0 - 20℃;
To a solution of commercially available ethyl 2-diethoxyphosphorylacetate(9.5 g, 42.3 mmol) in THE (20 mL) was added NaH (1 .7 g, 42.3 mmol) at 0°C. The mixture solution was stirred at 0°C for 1 h. Then a solution ofcommercially available 1 ,4-dioxaspiro[4.5]decan-8-one (6 g, 38.5 mmol) in THE (5 mL) was added at 000. The solution was stirred at r.t overnight. The mixture was quenched with aqueous NH4CI and extracted with EtOAc, the organic layer was washed with brine, dried over anhydrous Na2SO4, concentrated to give the crude product which was purified by column to givereagent KR-46 (6.6 g, 69 percent yield) as a white solid. ESI-MS (Mi-i): 227.2; calc. for C12H1804: 226.1.

Reference: [1] Tetrahedron, 1994, vol. 50, # 4, p. 1093 - 1104
[2] Organic Letters, 2005, vol. 7, # 19, p. 4185 - 4188
[3] Patent: WO2015/94803, 2015, A1, . Location in patent: Paragraph 340
[4] Patent: WO2015/148868, 2015, A1, . Location in patent: Paragraph 0342
[5] Patent: WO2016/8582, 2016, A1, . Location in patent: Page/Page column 125
[6] Patent: CN105367555, 2016, A, . Location in patent: Paragraph 0488; 0489; 0490
[7] Patent: WO2016/190847, 2016, A1, . Location in patent: Paragraph 0350; 0374
[8] Patent: WO2017/21920, 2017, A1, . Location in patent: Paragraph 1102; 1103
[9] Patent: CN104974163, 2017, B, . Location in patent: Paragraph 0551; 0552; 0553; 0644; 0645; 0646
[10] Patent: CN104672250, 2017, B, . Location in patent: Paragraph 0520; 0521; 0522
[11] Synthesis (Germany), 2012, vol. 44, # 23, p. 3623 - 3632
[12] Tetrahedron Asymmetry, 2008, vol. 19, # 2, p. 176 - 185
[13] Patent: WO2016/73774, 2016, A2, . Location in patent: Paragraph 0341
[14] Patent: WO2016/73770, 2016, A1, . Location in patent: Paragraph 0334
[15] Patent: WO2016/73738, 2016, A2, . Location in patent: Paragraph 0567
[16] Patent: WO2017/192840, 2017, A1, . Location in patent: Paragraph 00187
[17] Patent: WO2018/39512, 2018, A1, . Location in patent: Paragraph 00175; 00188
[18] Tetrahedron, 1999, vol. 55, # 36, p. 11095 - 11108
[19] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 23, p. 6309 - 6323
[20] Patent: US2010/249095, 2010, A1, . Location in patent: Page/Page column 128-129
[21] Patent: WO2005/10008, 2005, A1, . Location in patent: Page/Page column 104-105
[22] Patent: WO2006/44524, 2006, A1, . Location in patent: Page/Page column 45
[23] Patent: CN105566324, 2016, A, . Location in patent: Paragraph 0303; 0304; 0305; 0306
[24] Patent: US2008/153843, 2008, A1, . Location in patent: Page/Page column 47-48
[25] Patent: WO2017/181177, 2017, A1, . Location in patent: Paragraph 0568-0571
[26] Journal of Medicinal Chemistry, 2016, vol. 59, # 19, p. 8967 - 9004
[27] Patent: WO2014/131855, 2014, A1, . Location in patent: Page/Page column 65; 66
[28] Tetrahedron Letters, 1992, vol. 33, # 32, p. 4581 - 4584
[29] Journal of the Chemical Society, Chemical Communications, 1988, # 6, p. 425 - 426
[30] Patent: US2010/222324, 2010, A1, . Location in patent: Page/Page column 58
[31] Patent: WO2010/103429, 2010, A1, . Location in patent: Page/Page column 33
[32] Organic Letters, 2011, vol. 13, # 7, p. 1698 - 1701
[33] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 6, p. 1880 - 1886
[34] Patent: WO2011/146371, 2011, A1, . Location in patent: Page/Page column 24-25
[35] Patent: WO2014/89365, 2014, A1, . Location in patent: Paragraph 00395
[36] Patent: WO2018/93716, 2018, A1, . Location in patent: Page/Page column 20; 22; 23
  • 3
  • [ 4746-97-8 ]
  • [ 311-46-6 ]
  • [ 51656-91-8 ]
YieldReaction ConditionsOperation in experiment
86%
Stage #1: With potassium <i>tert</i>-butylate In N,N-dimethyl-formamide at 0 - 20℃; for 1 h;
Stage #2: at 0 - 20℃; for 16 h;
Triethylphosphono acetate (6lmL, 0.3Omol) was added to a suspention KOBu-t(33g, 0.3Omol) in DMF (200mL) at 0 00, stirred for lh at RT. A solution of 1,4- dioxaspiro[4.5]decan-8-one (40g, 0.25mo1) in DMF (200mL) was added at 0 C and the whole then stirred for 16h at RT. The reaction mixture was quenched with sat NH4CI solutionand extracted with ethyl acetate (2X500mL). The combined organic layer was washed with water, brine,dried over Na2SO4 and distilled under reduced pressure to afford crude, which was purified by column chromatography (silica gel; 60-l20mesh); the product eluted with 10- 15percentethyl acetate in hexane to yield 50.Og (86percent) of Ethyl-2-(1,4-dioxaspiro-[4.5]-decan-8- ylidene)-acetate as liquid.
Reference: [1] Patent: WO2016/8582, 2016, A1, . Location in patent: Page/Page column 65
[2] Journal of the American Chemical Society, 1991, vol. 113, # 21, p. 8016 - 8024
[3] Tetrahedron Letters, 1993, vol. 34, # 22, p. 3505 - 3508
  • 4
  • [ 867-13-0 ]
  • [ 637-88-7 ]
  • [ 51656-91-8 ]
YieldReaction ConditionsOperation in experiment
76%
Stage #1: With sodium hydride In tetrahydrofuran at 0 - 5℃; for 1 h;
Stage #2: at 20℃; for 16 h;
Step 1:
(1,4-Dioxa-spiro[4.5]dec-8-ylidene)-acetic acid ethyl ester
Triethyl phosphonoacetate (1.14 ml, 7.04 mmol) was dissolved in 15 ml THF and cooled to 0-5° C. Sodium hydride (310 mg, 7.04 mmol, 55percent) was added and the reaction mixture stirred for 1 hour at 0-5° C. 1,4-Cyclohexanedione (1.0 g, 6.40 mmol) dissolved in 10 ml THF was added drop wise and stirred for 16 hours at room temperature.
The reaction mixture was quenched with saturated NaHCO3-solution and extracted two times with ethyl acetate.
The organic extracts were washed with brine, dried with sodium sulfate, filtered and evaporated.
The crude product was purified by flash chromatography on silica gel (heptane/ethyl acetate 90:10-->0:100 gradient).
The desired compound was obtained as a colourless liquid (1.10 g, 76percent), MS: m/e=227.2 (M+H+).
Reference: [1] Patent: US2009/42943, 2009, A1, . Location in patent: Page/Page column 15
  • 5
  • [ 4746-97-8 ]
  • [ 1099-45-2 ]
  • [ 51656-91-8 ]
YieldReaction ConditionsOperation in experiment
90% for 24 h; Heating / reflux Preparation of (l,4-Dioxa-spiro[4.5]dec-8-ylidene)-acetic acid ethyl ester 22; A solution of 1,4-cycloliexanedionemonoetliylketal 20 (6g, 40mmol) and ethyl- (triphenylphosphoranylidene)acetate 22 (15g, 44mmol) in dry benzene (80ml) were refluxed under argon for 24hours. The solvent was removed under vacuum and product purified by flash chromatography to give the product in 90percent.
Reference: [1] Angewandte Chemie - International Edition, 2007, vol. 46, # 33, p. 6278 - 6283
[2] Patent: US2007/265243, 2007, A1, . Location in patent: Page/Page column 3
[3] Organic and Biomolecular Chemistry, 2006, vol. 4, # 24, p. 4431 - 4436
[4] Patent: WO2008/38030, 2008, A2, . Location in patent: Page/Page column 51
[5] Tetrahedron, 1995, vol. 51, # 37, p. 10259 - 10280
  • 6
  • [ 107-21-1 ]
  • [ 159454-98-5 ]
  • [ 51656-91-8 ]
Reference: [1] Tetrahedron Letters, 1996, vol. 37, # 10, p. 1683 - 1686
[2] Synlett, 2001, # 12, p. 1986 - 1988
[3] Tetrahedron, 2000, vol. 56, # 41, p. 8189 - 8195
  • 7
  • [ 107-83-5 ]
  • [ 1099-45-2 ]
  • [ 51656-91-8 ]
Reference: [1] Patent: US2001/9912, 2001, A1,
  • 8
  • [ 4746-97-8 ]
  • [ 51656-91-8 ]
Reference: [1] Patent: US2008/63814, 2008, A1,
  • 9
  • [ 4746-97-8 ]
  • [ 51656-91-8 ]
Reference: [1] Patent: US2008/75891, 2008, A1,
  • 10
  • [ 637-88-7 ]
  • [ 51656-91-8 ]
Reference: [1] Synlett, 2001, # 12, p. 1986 - 1988
[2] Tetrahedron, 2000, vol. 56, # 41, p. 8189 - 8195
[3] Tetrahedron Letters, 1996, vol. 37, # 10, p. 1683 - 1686
  • 11
  • [ 4746-97-8 ]
  • [ 35752-46-6 ]
  • [ 51656-91-8 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 23, p. 4143 - 4146
  • 12
  • [ 4746-97-8 ]
  • [ 38868-10-9 ]
  • [ 51656-91-8 ]
Reference: [1] Liebigs Annalen der Chemie, 1994, # 9, p. 901 - 910
  • 13
  • [ 51656-91-8 ]
  • [ 58012-34-3 ]
Reference: [1] Patent: WO2011/146371, 2011, A1,
[2] Patent: WO2014/89365, 2014, A1,
[3] Patent: WO2014/131855, 2014, A1,
[4] Patent: WO2016/73774, 2016, A2,
[5] Patent: WO2016/73770, 2016, A1,
[6] Journal of Medicinal Chemistry, 2016, vol. 59, # 19, p. 8967 - 9004
[7] Patent: WO2018/39512, 2018, A1,
Recommend Products
Same Skeleton Products

Technical Information

• 1,4-Addition of an Amine to a Conjugated Enone • 1,4-Addition of an Amine to a Conjugated Enone • 1,4-Additions of Organometallic Reagents • Acid-Catalyzed Equilibration of Alkenes • Acid-Catalyzed Rearrangement of Alkenes • Acyl Group Substitution • Addition of a Hydrogen Halide to an Internal Alkyne • Addition of Hydrogen Halides Forms Geminal Dihaloalkanes • Addition of Radicals to Alkenes • Alcohols Convert Acyl Chlorides into Esters • Alcoholysis of Anhydrides • Aldol Condensation • Alkene Hydration • Alkenes React with Ozone to Produce Carbonyl Compounds • Alkylation of Enolate Ions • Allylic Deprotonation • Allylic Halides Undergo SN1 Reactions • Allylic Substitution • Amines Convert Esters into Amides • Base-Catalyzed Hydration of α,β -Unsaturated Aldehydes and Ketones • Baylis-Hillman Reaction • Bouveault-Blanc Reduction • Brown Hydroboration • Carbene Addition to Double Bonds • Catalytic Hydrogenation • Catalytic Hydrogenation of Alkenes • Claisen Condensations Produce β-Dicarbonyl Compounds • Claisen Condensations Produce β-Dicarbonyl Compounds • Complex Metal Hydride Reductions • Conjugated Enone Takes Part in 1,4-Additions • Convert Esters into Aldehydes Using a Milder Reducing Agent • Decarboxylation of 3-Ketoacids Yields Ketones • Deprotection of Cbz-Amino Acids • Deprotonation of a Carbonyl Compound at the α -Carbon • Dimerization, Oligomerization of Alkenes • Dissolving-Metal Reduction of an Alkyne • Electrocyclic Reactions • Electrophilic Addition of Halogen to Alkynes • Electrophilic Addition of HX to Alkenes • Elimination from Dihaloalkanes to Give Haloalkenes • Enamine Formation • Enamines Can Be Used to Prepare Alkylated Aldehydes • Enol-Keto Equilibration • Epoxidation • Epoxidation by Peroxycarboxylic Acids • Ester Cleavage • Ester Hydrolysis • Ether Synthesis by Oxymercuration-Demercuration • Exclusive 1,4-Addition of a Lithium Organocuprate • Friedel-Crafts Alkylation Using Alkenes • Friedel-Crafts Alkylations of Benzene Using Alkenes • Grignard Reagents Transform Esters into Alcohols • Halogen and Alcohols Add to Alkenes by Electrophilic Attack • Halogen and Alcohols Add to Alkenes by Electrophilic Attack • Halogenation • Halogenation of Alkenes • Halogenation-double Dehydrohalogenation • Hantzsch Pyridine Synthesis • Heck Reaction • Hydroboration-Oxidation • Hydrogen Bromide Add to Alkenes in Anti-Markovnikov Fashion • Hydrogenation • Hydrogenation by Palladium on Carbon Gives the Saturated Carbonyl Compound • Hydrogenation with Lindlar Catalyst • Hydrogenation with Lindlar Catalyst • Hydroxylation • Isomerization of β, γ -Unsaturated Carbonyl Compounds • Ketones Undergo Mixed Claisen Reactions to Form β-Dicarbonyl Compounds • Lithium Organocuprate may Add to the α ,β -Unsaturated Carbonyl Function in 1,4-Fashion • Michael Addition • Osmium Tetroxide Reacts with Alkenes to Give Vicinal Diols • Oxidation of Alcohols to Carbonyl Compounds • Oxidative Cleavage of Double Bonds • Oxymercuration-Demercuration • Paternò-Büchi Reaction • Pauson-Khand Cyclopentenone Synthesis • Polymerization of Alkenes • Preparation of Alkenes • Preparation of Alkenes by Dehydration of Alcohols • Preparation of Alkenes by Dehydration of Alcohols • Prins Reaction • Radical Addition of a Thiol to an Alkene • Radical Addition of HBr to Terminal Alkynes • Radical Addition of HBr to Terminal Alkynes • Radical Allylic Substitution • Reactions of Alkenes • Reactions of Amines • Reactions with Organometallic Reagents • Reduction of an Ester to an Alcohol • Reduction of an Ester to an Aldehyde • Reductive Amination • Sharpless Asymmetric Amino Hydroxylation • Sharpless Asymmetric Dihydroxylation • Specialized Acylation Reagents-Carbodiimides and Related Reagents • Specialized Acylation Reagents-Vilsmeier Reagent • The Cycloaddition of Dienes to Alkenes Gives Cyclohexenes • The Heck Reaction • The Wittig Reaction • Transesterification • Vicinal Anti Dihydroxylation of Alkenes • Wacker Oxidation • Woodward Cis-Dihydroxylation
Historical Records

Related Functional Groups of
[ 51656-91-8 ]

Alkenes

Chemical Structure| 55750-84-0

[ 55750-84-0 ]

Crocin II

Similarity: 0.75

Chemical Structure| 6990-06-3

[ 6990-06-3 ]

(Z)-2-((3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetoxy-3,11-dihydroxy-4,8,10,14-tetramethyldodecahydro-1H-cyclopenta[a]phenanthren-17(2H,10H,14H)-ylidene)-6-methylhept-5-enoic acid

Similarity: 0.70

Chemical Structure| 14216-03-6

[ 14216-03-6 ]

(4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bS)-(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl 10-(((2S,3R,4S,5S)-4,5-dihydroxy-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate

Similarity: 0.68

Chemical Structure| 25662-28-6

[ 25662-28-6 ]

Methyl 1-cyclopentene-1-carboxylate

Similarity: 0.65

Chemical Structure| 18448-47-0

[ 18448-47-0 ]

Methyl cyclohex-1-enecarboxylate

Similarity: 0.65

Esters

Chemical Structure| 13137-64-9

[ 13137-64-9 ]

4-((3S,5S,8R,9S,10R,13R,14S,17R)-5,14-Dihydroxy-3-(((2R,4S,5R,6R)-4-methoxy-6-methyl-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one

Similarity: 0.78

Chemical Structure| 55750-84-0

[ 55750-84-0 ]

Crocin II

Similarity: 0.75

Chemical Structure| 15356-74-8

[ 15356-74-8 ]

4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one

Similarity: 0.70

Chemical Structure| 17092-92-1

[ 17092-92-1 ]

(R)-4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one

Similarity: 0.70

Chemical Structure| 6990-06-3

[ 6990-06-3 ]

(Z)-2-((3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetoxy-3,11-dihydroxy-4,8,10,14-tetramethyldodecahydro-1H-cyclopenta[a]phenanthren-17(2H,10H,14H)-ylidene)-6-methylhept-5-enoic acid

Similarity: 0.70

Related Parent Nucleus of
[ 51656-91-8 ]

Aliphatic Heterocycles

Chemical Structure| 55750-84-0

[ 55750-84-0 ]

Crocin II

Similarity: 0.75

Chemical Structure| 15356-74-8

[ 15356-74-8 ]

4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one

Similarity: 0.70

Chemical Structure| 1489-97-0

[ 1489-97-0 ]

Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.64

Chemical Structure| 78285-90-2

[ 78285-90-2 ]

(4aR,5R,6aS,6bR,10S,12aR,12bR,14bR)-5-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylic acid

Similarity: 0.63

Chemical Structure| 189509-22-6

[ 189509-22-6 ]

Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate

Similarity: 0.63

Spiroes

Chemical Structure| 1489-97-0

[ 1489-97-0 ]

Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.64

Chemical Structure| 24730-88-9

[ 24730-88-9 ]

Ethyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.63

Chemical Structure| 189509-22-6

[ 189509-22-6 ]

Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate

Similarity: 0.63

Chemical Structure| 26845-47-6

[ 26845-47-6 ]

Methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.62

Chemical Structure| 87787-08-4

[ 87787-08-4 ]

Methyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.61

Dioxolanes

Chemical Structure| 1489-97-0

[ 1489-97-0 ]

Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.64

Chemical Structure| 15042-01-0

[ 15042-01-0 ]

(R)-5-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-3,4-dihydroxyfuran-2(5H)-one

Similarity: 0.63

Chemical Structure| 24730-88-9

[ 24730-88-9 ]

Ethyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.63

Chemical Structure| 189509-22-6

[ 189509-22-6 ]

Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate

Similarity: 0.63

Chemical Structure| 6413-10-1

[ 6413-10-1 ]

Ethyl 2-(2-methyl-1,3-dioxolan-2-yl)acetate

Similarity: 0.63

; ;